Network origin in Kevin Trapp first degree
| Entity | Entity type | Industry | |
|---|---|---|---|
| Public Company | Pharmaceuticals: Major | 47 | |
| Public Company | Pharmaceuticals: Major | 20 |
Chart of Companies connected to the second degree
Multi-company connection
Companies connected to Kevin Trapp via their personal network
| Company | Sector | Related people | Main position |
|---|---|---|---|
| MERCK & CO., INC. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal Chief Tech/Sci/R&D Officer | |
| University of Connecticut | College/University | Undergraduate Degree Undergraduate Degree Undergraduate Degree | |
| OMEGA THERAPEUTICS, INC. | Biotechnology | Director/Board Member Director/Board Member Director of Finance/CFO | |
Flagship Pioneering
 Flagship Pioneering Investment ManagersFinance Flagship Pioneering (Flagship Pioneering) is a venture capital firm founded in 1982 by Ed M Kania and Noubar B Afeyan. The firm is headquartered in Cambridge, Massachusetts. | Investment Managers | Private Equity Investor Private Equity Investor Private Equity Investor | |
| Rutgers State University of New Jersey | College/University | Undergraduate Degree Doctorate Degree Undergraduate Degree | |
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Biotechnology | Corporate Officer/Principal Sales & Marketing Corporate Officer/Principal | |
| NOVO NORDISK A/S | Pharmaceuticals: Major | Director/Board Member Corporate Officer/Principal Corporate Officer/Principal | |
Artiva Biotherapeutics, Inc.
 Artiva Biotherapeutics, Inc. BiotechnologyHealth Technology Artiva Biotherapeutics, Inc. operates as a biotechnology company for the treatment of hematologic cancers. It offers NK cell therapies for cancer. The company was founded by Thomas J. Farrell in 2019 and is headquartered in San Diego, CA. | Biotechnology | Chairman Director/Board Member Director/Board Member | |
| Yale School of Medicine | College/University | Corporate Officer/Principal Doctorate Degree Corporate Officer/Principal | |
| Georgetown University | College/University | Graduate Degree Masters Business Admin Undergraduate Degree | |
| AMGEN INC. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer Chief Tech/Sci/R&D Officer Sales & Marketing | |
| Imperial College London | College/University | Graduate Degree Corporate Officer/Principal Graduate Degree | |
| PHARVARIS N.V. | Pharmaceuticals: Major | Director/Board Member General Counsel | |
| EGETIS THERAPEUTICS AB | Pharmaceuticals: Major | Director/Board Member General Counsel | |
| ADC THERAPEUTICS SA | Pharmaceuticals: Major | Corporate Officer/Principal Director/Board Member | |
| IPSEN | Pharmaceuticals: Major | Director of Finance/CFO Corporate Officer/Principal | |
| GENOCEA BIOSCIENCES, INC. | Biotechnology | Director/Board Member Director/Board Member | |
| Stephen M. Ross School of Business | College/University | Masters Business Admin Undergraduate Degree | |
| Massachusetts Institute of Technology | College/University | Graduate Degree Undergraduate Degree | |
| NOVARTIS AG | Pharmaceuticals: Major | Director of Finance/CFO Corporate Officer/Principal | |
Transcelerate Biopharma, Inc.
 Transcelerate Biopharma, Inc. BiotechnologyHealth Technology Transcelerate Biopharma, Inc. is a non-profit consortium that collaborates with pharmaceutical and biotechnology companies to improve the delivery of new medicines. The non-profit company is based in King of Prussia, PA. The organization's mission is to identify, prioritize, design, and facilitate implementation of solutions to drive the efficient, effective, and high-quality delivery of new medicines. Transcelerate has 20 member companies and 30+ initiatives focused on improving the patient and site experience, enhancing sponsor efficiencies and drug safety, and harmonizing processes and sharing information. The company was founded by Garry Arthur Neil, and Janice Chang has been the CEO of the company since 2014. | Biotechnology | Director/Board Member Chairman | |
5AM Venture Management LLC
 5AM Venture Management LLC Investment ManagersFinance 5AM Venture Management LLC (5AM Ventures) is an Independent Venture Capital firm founded in 2002 by Andrew J. Schwab, Carin M. Rollins and John D. Diekman. The firm is headquartered in San Francisco, US. | Investment Managers | Private Equity Investor Private Equity Investor | |
| IDEAYA BIOSCIENCES, INC. | Pharmaceuticals: Major | Director/Board Member Chief Tech/Sci/R&D Officer | |
| BRAINSTORM CELL THERAPEUTICS INC. | Biotechnology | General Counsel General Counsel | |
| C4 THERAPEUTICS, INC. | Biotechnology | Chairman Director/Board Member | |
One Biosciences SAS
 One Biosciences SAS BiotechnologyHealth Technology One Biosciences SAS engages in single-cell technology research and development activities. It aims to identify new therapeutics for difficult-to-treat diseases. The company was founded by Céline Vallot, Magali Richard, and David Schilansky and is headquartered in Paris, France. | Biotechnology | Founder Founder | |
| The Boston Consulting Group | Consultant / Advisor Consultant / Advisor | ||
Home Biosciences SAS
 Home Biosciences SAS BiotechnologyHealth Technology Home Biosciences SAS is a biotech venture builder that partners with academics and scientists to develop life-changing therapies for patients. The company is based in France and has subsidiaries in the country. The French company's operating model allows its teams to focus on scientific and operational excellence to expedite and de-risk the discovery and development paths of its projects, which are housed in dedicated ventures and fully financed by Home Biosciences. Home Biosciences was founded in 2019 by Magali Richard and David S. Schilansky, who has been the CEO since its inception. | Biotechnology | Chief Executive Officer Founder | |
Galderma International SAS
 Galderma International SAS Pharmaceuticals: MajorHealth Technology Galderma SA develops and markets therapeutic and aesthetic solutions for dermatology. It provides medical dermatological solutions for acne, rosacea, psoriasis and other steroid-responsive dermatoses, onychomycosis, pigmentary disorders, skin cancer and medical aesthetic and corrective solutions for skin senescence. The company was founded in 1981 and is headquartered in Paris, France. | Pharmaceuticals: Major | General Counsel Director of Finance/CFO | |
| ASTRAZENECA PLC | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
| CELGENE | Biotechnology | President Chief Tech/Sci/R&D Officer | |
| University of the Sciences in Philadelphia | College/University | Doctorate Degree Graduate Degree | |
| BIOHAVEN PHARMACEUTICAL HOLDING COMPANY LTD. | Pharmaceuticals: Major | Chief Executive Officer Director/Board Member | |
| Albert Einstein College of Medicine, Inc. | College/University | Doctorate Degree Doctorate Degree | |
| BIOHAVEN LTD. | Pharmaceuticals: Major | Chief Executive Officer Chief Tech/Sci/R&D Officer | |
Duke University
 Duke University Other Consumer ServicesConsumer Services Duke University is an academic university that offers undergraduate, graduate and professional programs. It also has publications and research services. The university was founded in 1838 and is headquartered in Durham, NC. | College/University | Undergraduate Degree Undergraduate Degree | |
| Universidad Nacional Autónoma de México | College/University | Doctorate Degree Doctorate Degree | |
Novartis Oncology, Inc.
 Novartis Oncology, Inc. Pharmaceuticals: MajorHealth Technology Novartis Oncology, Inc. provides healthcare solutions. The firm offers medicines, eye care and generic pharmaceuticals. It also offers patient declaration, patient support and assistance, and additional resources. The company is headquartered in East Hanover, NJ. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
| The Wharton School of the University of Pennsylvania | College/University | Masters Business Admin Masters Business Admin | |
| Kellogg School of Management | College/University | Graduate Degree Masters Business Admin | |
| GE HEALTHCARE TECHNOLOGIES INC. | Medical Specialties | Chief Executive Officer Public Communications Contact | |
| BAXTER INTERNATIONAL INC. | Medical Specialties | Corporate Officer/Principal Corporate Officer/Principal | |
Shionogi, Inc.
 Shionogi, Inc. Pharmaceuticals: MajorHealth Technology Part of Shionogi & Co., Ltd., Shionogi, Inc. is a pharmaceutical company based in Florham Park, NJ. Since 1878, the company has been utilizing science to address health challenges and has discovered several novel antibiotics and medications for HIV and influenza. Shionogi conducts ongoing research into established products and new antibiotic compounds, as well as developing an investigational antiviral for COVID-19. The company is committed to pursuing discovery through partnerships, including collaboration with scientists through investigator-initiated research. Shionogi is dedicated to advancing the greater good by developing, partnering, and commercializing medicine to treat serious unmet medical needs in infectious disease and other areas of high medical need including neurology and cardiovascular disease. Nathan McCutcheon has been the CEO of the company since 2019. | Pharmaceuticals: Major | Corporate Officer/Principal | |
Biohaven Pharmaceuticals, Inc.
 Biohaven Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Biohaven Pharmaceuticals, Inc. engaged in the identification and development of clinical stage compounds targeting the glutamatergic system. The company in July 2013 and is headquartered in New Haven, CT. | Miscellaneous Commercial Services | Chief Executive Officer | |
Novartis International AG
 Novartis International AG Pharmaceuticals: MajorHealth Technology Novartis International AG manages the Novartis Group. It provides administrative, financial, legal, and technical services. It also offers scientific consultation to the Group. The company was founded on December 13, 1989 and is headquartered in Basel, Switzerland. | Pharmaceuticals: Major | Corporate Officer/Principal | |
| VANDA PHARMACEUTICALS INC. | Pharmaceuticals: Major | Corporate Officer/Principal | |
PharmAkea, Inc.
 PharmAkea, Inc. Pharmaceuticals: MajorHealth Technology PharmAkea, Inc. develops small molecule drug candidates against protein targets involved in fibro proliferative diseases. It discovers and develops small molecule therapeutics directed at cancer and fibrotic diseases. The company was founded by John Howard Hutchinson, Kevin Holme, and Jilly Evans in 2012 and is headquartered in San Diego, CA. | Pharmaceuticals: Major | Director/Board Member |
Statistics
International
| United States | 34 |
| France | 6 |
| Switzerland | 4 |
| United Kingdom | 3 |
| Mexico | 3 |
Sectoral
| Health Technology | 32 |
| Consumer Services | 14 |
| Finance | 5 |
| Commercial Services | 2 |
Operational
| Director/Board Member | 161 |
| Corporate Officer/Principal | 150 |
| Independent Dir/Board Member | 56 |
| Chief Tech/Sci/R&D Officer | 52 |
| Undergraduate Degree | 49 |
Most connected contacts
| Insiders | |
|---|---|
| James Cornelius | 23 |
| Viviane Monges | 22 |
| Thomas Lynch | 20 |
| Brian Daniels | 20 |
| Matt Roden | 18 |
| Peter Arduini | 16 |
| Lena Elisabeth Svanberg | 16 |
| Daniel Tassé | 16 |
| Julie Hambleton | 15 |
| Vladimir Coric | 14 |
| Elliott Levy | 14 |
| Andres Gutiérrez | 13 |
| Rupert Vessey | 13 |
| Lewis B. Campbell | 12 |
| Jennifer Herron | 12 |
- Stock Market
- Insiders
- Kevin Trapp
- Company connections
